How Anti-Vaccine Sentiment Took Hold in the United States

Source: The New York Times Date: September 23, 2019 Author: Jan Hoffman As families face back-to-school medical requirements this month, the country feels the impact of a vaccine resistance movement decades in the making.   The question is often whispered, the questioners sheepish. But increasingly, parents at the Central Park playground where Dr. Elizabeth A. Comen takes her young children have been asking her: “Do you vaccinate your kids?” Dr. Comen, an oncologist who has treated patients for cancers related to the human papillomavirus that a vaccine can now prevent, replies emphatically: Absolutely. She never imagined she would be getting such queries. Yet these playground exchanges are reflective of the national conversation at the end of the second decade of the 21st century — a time of stunning scientific and medical advances but also a time when the United States may, next month, lose its World Health Organization designation as a country that has eliminated measles, because of outbreaks this year. The W.H.O. has listed vaccine hesitancy as one of the top threats to global health. As millions of families face back-to-school medical requirements and forms this month, the contentiousness surrounding vaccines is heating up again, with possibly even more fervor. Though the situation may seem improbable to some, anti-vaccine sentiment has been building for decades, a byproduct of an internet humming with rumor and misinformation; the backlash against Big Pharma; an infatuation with celebrities that gives special credence to the anti-immunization statements from actors like Jenny McCarthy, Jim Carrey and Alicia Silverstone, the rapper Kevin Gates and Robert F. [...]

2019-09-24T11:31:18-07:00September, 2019|Oral Cancer News|

NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

Source: www.medicine.wustl.eduAuthor: Washington University School of Medicine in St. Louis Staff Approximately 79 million people in the United States are currently infected with a human papillomavirus (HPV) according to the Centers for Disease Control and Prevention (CDC), and 14 million new infections occur each year. Several types of high-risk HPV are responsible for the vast majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers. The CDC also reports that each year in the U.S., 27,000 men and women are diagnosed with an HPV-related cancer, which amounts to a new case every 20 minutes. Even though many of these HPV-related cancers are preventable with a safe and effective vaccine, HPV vaccination rates across the U.S. remain low. Together we, a group of the National Cancer Institute (NCI)- designated Cancer Centers, recognize these low rates of HPV vaccination as a serious public health threat. HPV vaccination represents a rare opportunity to prevent many cases of cancer that is tragically underused. As national leaders in cancer research and clinical care, we are compelled to jointly issue this call to action. According to a 2015 CDC report, only 40 percent of girls and 21 percent of boys in the U.S. are receiving the recommended three doses of the HPV vaccine. This falls far short of the goal of 80 percent by the end of this decade, set forth by the U.S. Department of Health and Human Service’s Healthy People 2020 mission. Furthermore, U.S. rates are significantly lower than those of countries such as [...]

2016-02-04T12:35:06-07:00February, 2016|Oral Cancer News|

U.S. Chamber of Commerce Works Globally to Fight Antismoking Measures

Source: www.nytimes.comAuthor: Danny Hakim  A demonstration against World No Tobacco Day in Jakarta, Indonesia, in 2013. The U.S. Chamber of Commerce and its foreign affiliates have joined efforts to fight antismoking laws around the world. Credit Romeo Gacad/Agence France-Presse — Getty Images KIEV, Ukraine — A parliamentary hearing was convened here in March to consider an odd remnant of Ukraine’s corrupt, pre-revolutionary government. Three years ago, Ukraine filed an international legal challenge against Australia, over Australia’s right to enact antismoking laws on its own soil. To a number of lawmakers, the case seemed absurd, and they wanted to investigate why it was even being pursued. When it came time to defend the tobacco industry, a man named Taras Kachka spoke up. He argued that several “fantastic tobacco companies” had bought up Soviet-era factories and modernized them, and now they were exporting tobacco to many other countries. It was in Ukraine’s national interest, he said, to support investors in the country, even though they do not sell tobacco to Australia. Mr. Kachka was not a tobacco lobbyist or farmer or factory owner. He was the head of a Ukrainian affiliate of the U.S. Chamber of Commerce, America’s largest trade group. From Ukraine to Uruguay, Moldova to the Philippines, the U.S. Chamber of Commerce and its foreign affiliates have become the hammer for the tobacco industry, engaging in a worldwide effort to fight antismoking laws of all kinds, according to interviews with government ministers, lobbyists, lawmakers and public health groups in Asia, [...]

HPV Vaccine Found to Help with Cancers of Throat

Source: NY Times By: Donald G. McNeil Jr. A vaccine that protects women against cervical cancer also appears to protect them against throat cancers caused by oral sex, and presumably would protect men as well, according to a study released Thursday. Rates of this throat cancer have soared in the past 30 years, particularly among heterosexual middle-aged men. About 70 percent of oropharyngeal cancers are now caused by sexually transmitted viruses, up from 16 percent in the 1980s. The epidemic made headlines last month when the actor Michael Douglas told a British newspaper that his throat cancer had come from performing oral sex. Oncologists have assumed that the human papillomavirus vaccine, which is used to prevent cervical cancer, would also prevent this other type of cancer, but this was the first study to provide evidence. “This is a very nice paper,” said Dr. Marshall R. Posner, medical director for head and neck cancer at Mount Sinai Medical Center in New York, who was not involved in the study. “We expected this — that’s why we want everyone to vaccinate both boys and girls. But there’s been no proof.” The study, supported by the National Cancer Institute, found that Cervarix, made by GlaxoSmithKline, provided 93 percent protection against infection with the two types of human papillomavirus that cause most of the cancers. “We were surprised at how big the effect was,” said Dr. Rolando Herrero, head of prevention for the World Health Organization’s International Agency for Research on Cancer, and the [...]

2013-07-19T11:20:48-07:00July, 2013|Oral Cancer News|

High HPV Immunization Rates Achieved With PATH Initiative

Source: Medscape.com August 30, 2012 (Montreal, Quebec) — Exceptionally high immunization rates against human papillomavirus (HPV) have been achieved in target-aged girls in India, Peru, Uganda, and Vietnam as a result of a PATH initiative, researchers told delegates here at the Union for International Cancer Control World Cancer Congress 2012. Vivien Tsu, PhD, MPH, director of the HPV vaccines project at PATH, reported that a minimum of 80% — and in some countries well over 90% — of school-aged girls received at least 1 dose of the HPV vaccine in the 4 countries to which the initiative has been directed over the past several years. "The reason the program was successful in these countries, and likely many others, is that there is visible government endorsement and involvement in the program," Dr. Tsu explained. "For the most part, people trust that the government is trying to help them, so if the government is saying 'this is worth doing,' the community participates." As Dr. Tsu noted, cervical cancer — at least 70% of which is caused by HPV types 16 and 18 — is a major health issue for women in low- and middle-income countries, with a projected incidence in 2030 of more than 750,000 women. In North America and Europe, cytology has been extremely effective in detecting cervical cancer and, more important, precursor lesions. However, in low- and middle-income countries, "cytology has failed to have much of an impact," Dr. Tsu explained, because these countries lack the necessary resources to offer widespread [...]

2012-08-31T11:09:43-07:00August, 2012|Oral Cancer News|

1 of 6 cancer deaths worldwide caused by preventable infections

Source: Los Angeles Times One in every six cancer deaths worldwide is caused by preventable infections, a total of 1.5 million deaths yearly that could be halted by widespread vaccination programs, researchers reported Wednesday. Since 1990, that number has grown by about half a million, suggesting that vaccination programs are losing ground in the battle rather than gaining it.  The vast majority of the cases are caused by three viruses and a bacterium, which are the leading causes of gastric, liver and cervical cancers. Cervical cancers account for about half of the infection-related cancers in women, while liver and gastric cancers account for about 80% of those in men. The causes of many cancers are largely unknown, but genetics and poor luck play big roles. The World Health Organization estimated in 2004 that nine lifestyle and environmental factors -- smoking being a particularly large one -- account for as many as 35% of the 12.7 million cancers that occur each year, about twice the proportion now linked to infections. Cervical cancers are caused primarily by the human papilloma virus (HPV), as are anal and penile tumors. Stomach cancers are caused by the bacterium Helicobacter pylori. The hepatitis B and hepatitis C viruses cause liver cancer.  All such infections are readily preventable by vaccination. Other less common agents include the Epstein-Barr virus, which causes nasopharynx tumors and Hodgkin's lymphoma; human herpes virus type 8, which causes Kaposi's sarcoma, usually in conjunction with HIV; and the parasite Schistosoma haematobium, which causes bladder [...]

2012-05-09T13:43:12-07:00May, 2012|Oral Cancer News|

Global oral cancer rates to rise 63% by 2030

Source:DrBiscupid.com The International Agency for Research on Cancer, part of the World Health Organization (WHO), predicts that more than 790,000 people worldwide will be diagnosed with oral cancer by 2030, an increase of more than 63% compared with 2008. Mortality rates for mouth cancer are predicted to be even higher with more than 460,000 deaths forecast by 2030, more than 67% higher than 2008 rates, according to the International Dental Health Foundation (IDHF). The WHO believes modifying and avoiding risk factors could result in up to 30% of cancers being avoided, noted Nigel Carter, BDS, chief executive of the IDHF. "Although cancer is not wholly preventable, mouth cancer is very closely related to lifestyle choices. Making more people aware of the risks and symptoms for mouth cancer will undoubtedly save lives," Dr. Carter stated in a press release. "Forecasts for the incidence and mortality of mouth cancer are very grim. We hope more countries will develop their own oral cancer action campaigns to raise awareness." November is Mouth Cancer Action Month, sponsored annually by the IDHF. This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

2011-12-27T11:27:28-07:00December, 2011|Oral Cancer News|

Global Rise in Cancer Cost $300 Billion in 2010, Harvard Economist Says During Press Briefing Hosted by the American Cancer Society and the United Nations

23 June 2011 United Nations — Newly diagnosed cancer cases cost the global economy $300 billion in 2010, as illnesses once believed to be largely confined to wealthier countries took hold in developing nations, a Harvard University economist said during a press briefing hosted by the American Cancer Society Global Health Programs and the United Nations Department of Public Information. Tobacco use, alcohol intake, obesity and decreased physical activity have grown in poorer countries, causing the rise of cancer and diabetes, said David E. Bloom, professor of economics and demography at Harvard’s School of Public Health in Boston. Bloom and other researchers held a briefing today in advance of the United Nations High Level Meeting on noncommunicable diseases. The Sept. 19-20 meeting will be the first gathering of the UN Assembly dealing with cancer, cardiovascular illness, chronic lung conditions and diabetes. These diseases cause 60 percent of deaths worldwide, killing 36.1 million people annually, according to an April report by the World Health Organization. “Noncommunicable diseases will evolve into a staggering economic burden in the coming years,” Bloom said. “It’s a huge impediment to the mitigation of poverty.” Bloom said treating newly diagnosed cancer cases cost $300 billion globally in 2010, and obstructive pulmonary disease -- often correlated with smoking tobacco -- costs $4 billion a year. Not Confined to Health “Economic policy makers like ministers of finance and ministers of planning see noncommunicable diseases as an issue confined to the health sector,” a misperception that needs to be addressed, [...]

Philip Morris Int’l purchases license to nicotine system

Source: Associated Press Cigarette maker Philip Morris International Inc. has purchased the rights to a technology that lets users inhale nicotine without smoking. The world's largest nongovernmental cigarette seller told The Associated Press on Thursday it has bought the patent for an aerosol nicotine-delivery system developed by Jed Rose, director of the Center for Nicotine and Smoking Cessation Research at Duke University in Durham, N.C. The school does not have a role in Rose's agreement with the company and won't receive any money. Terms were not disclosed. "By avoiding the burning process altogether, finding a way of giving smokers nicotine to inhale but without those toxic substances that we can reduce the death and disease associated with smoking," said Rose, who led the initial studies in the early 1980s that helped pave the way for commercial nicotine patches as a smoking cessation treatment. "Hopefully it's a wave of the future that inhaling combusted, burning tobacco will someday be a thing of the past." Rose said the next step is for Philip Morris International, with offices in New York and Lausanne, Switzerland, to develop a commercial product using the technology. The system differs from current medicinal nicotine inhalers available on the market as stop-smoking aids because it delivers nicotine more rapidly to mimic the nicotine "hit" a cigarette provides smokers. "The other methods of delivering nicotine fall short of providing smokers with the satisfaction that they crave," Rose said. The move is an "important step in our efforts to develop products [...]

Modest Drinking can Heighten your Risk for Cancer

Source: MedScape.org   April 14, 2011 — "A considerable proportion of the most common and most lethal cancers is attributable to former and current alcohol consumption," concludes a large European study published online April 8 in BMJ. The researchers attribute about 10% of all cancers in men and about 3% of all cancers in women to previous and current alcohol consumption. The estimates come from an analysis of data from the huge ongoing European Prospective Investigation Into Cancer (EPIC) and from representative data on alcohol consumption compiled by the World Health Organization (WHO). The risk increases even with drinking moderate amounts. "This research supports existing evidence that alcohol causes cancer and that the risk increases even with drinking moderate amounts," coauthor Naomi Allen, DPhil, an epidemiologist at Oxford University, United Kingdom, said in a statement. The original data in the EPIC study were collected from 1992 to 2000, so "the results from this study reflect the impact of people's drinking habits about 10 years ago," Dr. Allen noted. "People are drinking even more now than they were then, and this could lead to more people developing cancer because of alcohol in the future," she added. Data From 8 Countries The EPIC study, which is still ongoing, is one of the largest studies of diet and cancer ever conducted. It involved more than half a million people in Europe. For this analysis of alcohol and cancer, the researchers used EPIC data from 363,988 participants from 8 European countries — France, Italy, Spain, [...]

Go to Top